MITOMYCIN-C, VP16-213 COMBINATION AS 3RD LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER

被引：0
作者：
MANGA, GP
ALONSO, PLM
CARBUCCIA, HA
机构：
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1982年 / 7卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：227 / 229
页数：3
相关论文
共 50 条
[41]   A PHASE-II EVALUATION OF VP16-213 IN ADVANCED OVARIAN-CANCER [J].
HILLCOAT, B ;
BISHOP, J ;
CAMPBELL, J .
MEDICAL AND PEDIATRIC ONCOLOGY, 1983, 11 (03) :215-215
[42]   EVALUATION OF HEXAMETHYLMELAMINE, CIS-DIAMMINEDICHLOROPLATINUM AND MITOMYCIN-C IN ADVANCED BREAST-CANCER [J].
LAWSON, DH ;
MOORE, MR ;
SMALLEY, RV .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR) :369-369
[43]   MYELOSUPPRESSION AFTER METHOTREXATE, MITOXANTRONE, AND MITOMYCIN-C FOR TREATMENT OF ADVANCED BREAST-CANCER [J].
MARKS, A ;
GOODMAN, A ;
DOUGHERTY, S ;
ASHFORD, R .
LANCET, 1987, 1 (8538) :915-915
[44]   PROGESTIN (PN)-MITOMYCIN-C (MMC) SALVAGE THERAPY IN ADVANCED BREAST-CANCER [J].
FORMANEK, GA ;
COHEN, FB ;
LIPPMAN, AJ ;
RUIZ, AM ;
STEINBAUM, FL ;
DECTER, JA ;
CUSTODIO, MC .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR) :411-411
[45]   VP16-213 IN THE THERAPY OF SMALL CELL LUNG-CANCER (SCLC) - PRELIMINARY-RESULTS IN COMBINATION CHEMOTHERAPY [J].
MARTINEZ, J ;
ESCUDERO, C ;
RAMOS, SR ;
PANIZO, AG .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :240-240
[46]   EPIPODOPHYLLOTOXIN (VP16-213) IN SMALL CELL-CARCINOMA OF THE BRONCHUS RESISTANT TO INITIAL COMBINATION CHEMOTHERAPY [J].
HARPER, PG ;
DALLY, MB ;
GEDDES, DM ;
SPIRO, SG ;
SMYTH, JF ;
SOUHAMI, RL .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :179-180
[47]   MITOXANTRONE AND METHOTREXATE CHEMOTHERAPY WITH AND WITHOUT MITOMYCIN-C IN THE TREATMENT OF ADVANCED BREAST-CANCER - A RANDOMIZED CLINICAL-TRIAL [J].
STEIN, RC ;
BOWER, M ;
LAW, M ;
BLISS, JM ;
BARTON, C ;
GAZET, JC ;
FORD, HT ;
COOMBES, RC .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (12) :1963-1965
[48]   TREATMENT OF SMALL CELL LUNG-CANCER USING THE CYCLOPHOSPHAMIDE AND VP16-213 COMBINATION [J].
LARRIBA, JLG ;
ALVAREZ, YE ;
DEPAREDES, MLG ;
PEREZ, MAD ;
GALLEGO, AO ;
GARCIA, JMM .
BULLETIN DU CANCER, 1983, 70 (03) :214-214
[49]   A PILOT COMBINATION OF DIBROMODUCITOL, ADRIAMYCIN, AND TAMOXIFEN (DAT) VERSUS MITOMYCIN-C AND TAMOXIFEN (MT) FOR ADVANCED BREAST-CANCER [J].
CHANG, YC ;
FALKSON, G ;
TORMEY, D .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR) :147-147
[50]   A RANDOMIZED TRIAL COMPARING COMBINATION CHEMOTHERAPY USING MITOMYCIN-C, MITOXANTRONE AND METHOTREXATE (3M) WITH VINCRISTINE, ANTHRACYCLINE AND CYCLOPHOSPHAMIDE (VAC) IN ADVANCED BREAST-CANCER [J].
POWLES, TJ ;
JONES, AL ;
JUDSON, IR ;
HARDY, JR ;
ASHLEY, SE .
BRITISH JOURNAL OF CANCER, 1991, 64 (02) :406-410
12345